While in many epithelial malignancies it supports metabolic reprogramming, immune exclusion, and tumor progression, in specific tumor types such as GBM, LGG, OV, SARC, and TGCT, p62 may contribute to immune stimulation and potentially restrain tumor growth. This evidence concerns the gene SQSTM1 and glioblastoma.